1-1 of 1
for the VELCADE CAN2007 Study Group
Close
Sort by
Journal Articles

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

Clinical Trials & Observations
Donna E. Reece, Vaishali Sanchorawala, Ute Hegenbart, Giampaolo Merlini, Giovanni Palladini, Jean-Paul Fermand, Robert A. Vescio, Xiangyang Liu, Yusri A. Elsayed, Andrew Cakana, Raymond L. Comenzo, for the VELCADE CAN2007 Study Group
Journal: Blood
Blood (2009) 114 (8): 1489–1497.
https://doi.org/10.1182/blood-2009-02-203398
Published: 2009
Includes: Supplemental data